MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-09-14
DOI
10.1038/srep33153
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer
- (2016) Po-Han Lin et al. Oncotarget
- SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
- (2015) Kanako Okamoto et al. BMC Medical Genetics
- Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer
- (2015) Richarda M. de Voer et al. Scientific Reports
- MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk
- (2015) Stian Knappskog et al. Oncotarget
- Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649)
- (2015) Stian Knappskog et al. Oncotarget
- A DRD1 Polymorphism Predisposes to Lung Cancer among Those Exposed to Secondhand Smoke during Childhood
- (2014) A. I. Robles et al. Cancer Prevention Research
- Influence ofMDM2SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon
- (2014) Liv B. Gansmo et al. INTERNATIONAL JOURNAL OF CANCER
- MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer
- (2012) Bríd M. Ryan et al. INTERNATIONAL JOURNAL OF CANCER
- MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk
- (2012) Stian Knappskog et al. PLoS One
- Colorectal cancers choosing sides
- (2011) Cristina Albuquerque et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians
- (2011) Stian Knappskog et al. CANCER CELL
- SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer
- (2011) Stian Knappskog et al. EUROPEAN JOURNAL OF CANCER
- Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis
- (2009) Konstantinos P. Economopoulos et al. BREAST CANCER RESEARCH AND TREATMENT
- Association of MDM2 SNP309, Age of Onset, and Gender in Cutaneous Melanoma
- (2009) E. F. Firoz et al. CLINICAL CANCER RESEARCH
- MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism
- (2008) Fiona EM Paulin et al. BMC CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search